For Healthcare Professionals

Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)

clipboard-pencil

About the study

Children vary in the age at which they achieve night-time dryness; in almost all cases children will stop bed-wetting without any need for treatment. Use of absorbent pants for the management of nocturnal enuresis is controversial regarding the impact on the speed at which children become dry throughout the night. The aim of this study is to determine the effect of using DryNites absorbent pants in children with monosymptomatic nocturnal enuresis on the speed they become dry throughout the night compared with removing absorbent pants.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

  1. Patient aged between 4-8 years at the time of enrollment
  2. Have a clinical diagnosis of monosymptomatic primary NE
  3. Have been dry in the day for >/= 6 months prior to enrollment
  4. Have on average no more than 1 dry night per month during the past 6 months at enrollment
  5. Have an informed consent signed by the their parent(s)/carer(s)

EXCLUSION CRITERIA

  1. Children in foster/court care
  2. Have implemented any previous intervention to address NE (use of prescribed alarm schedule, desmopressin, imipramine, anticholinergics) or withdrawal of pants/nappies for > 7 days in the previous 6 months
  3. Have secondary NE
  4. Have wetting in the day
  5. Have faecal soiling
  6. Have known urinary tract disease
  7. Have diabetes
  8. Receive any regular intake of medication
  9. Have a known developmental/neurological disorder
  10. Have links to Kimberly-Clark of any kind (including family relations employed by Kimberly-Clark, holding stocks or share in Kimberly-Clark)
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall +91 9850072432Email iconEmail Study Center

Study’s details


Contition

Nocturnal Enuresis

Age

4+

Phase

N/A

Participants needed

120

Est. Completion Date

Dec 2022

Treatment type

Interventional


Sponsor

Kimberly-Clark Corporation

ClinicalTrials.gov identifier

NCT04620356

Study number

KCC-DN-001

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.